Industry & Economy
-
Bio-tech & Genetics
Independent status sought for drug authority
Our Bureau
New Delhi
,
Aug 22
The biotechnology industry has demanded that the new drug authority, being considered by the Ministry of Health and Family Welfare, be made an independent statutory body.
A scientific advisory board should be created for the purpose with persons of eminence who can guide its functioning.
Duty waiver
Industry representatives, who met the Indian Sub-Group on Clinical Research and Transfer of Biomaterials under the Indo-US Joint Industry Working Group on Biotechnology under the aegis of the FICCI, at a meeting chaired by the Secretary, Department of Biotechnology, Dr M.K. Bhan, also sought waiver of excise duty on equipment for biotechnology and medical research.
It was noted that the cost of chemicals and reagents sold by the US companies in India was much higher (up to 200 per cent) than in the US.
Import
The Government must consider providing Indian companies blanket permission of up to Rs 1 crore, for import of laboratory consumables to recognised R&D set-ups, it said.
More Stories on :
Bio-tech & Genetics |
Pharmaceuticals |
Regulatory Bodies & Rulings
Article
E-Mail
::
Comment
::
Syndication
::
Printer Friendly Page
|
